These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11334348)

  • 1. From receptor recognition mechanisms to bioinspired mimetic antagonists in HIV-1/cell docking.
    Dowd CS; Zhang W; Li C; Chaiken IM
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):327-35. PubMed ID: 11334348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences.
    Li C; Dowd CS; Zhang W; Chaiken IM
    J Pept Res; 2001 Jun; 57(6):507-18. PubMed ID: 11437954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.
    Dowd CS; Leavitt S; Babcock G; Godillot AP; Van Ryk D; Canziani GA; Sodroski J; Freire E; Chaiken IM
    Biochemistry; 2002 Jun; 41(22):7038-46. PubMed ID: 12033937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes.
    Kuzmina A; Vaknin K; Gdalevsky G; Vyazmensky M; Marks RS; Taube R; Engel S
    PLoS One; 2015; 10(12):e0144043. PubMed ID: 26629902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity.
    Richard J; Veillette M; Ding S; Zoubchenok D; Alsahafi N; Coutu M; Brassard N; Park J; Courter JR; Melillo B; Smith AB; Shaw GM; Hahn BH; Sodroski J; Kaufmann DE; Finzi A
    EBioMedicine; 2016 Jan; 3():122-134. PubMed ID: 26870823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
    Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.
    Pandey D; Podder A; Pandit M; Latha N
    J Biomol Struct Dyn; 2017 Sep; 35(12):2631-2644. PubMed ID: 27545652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.
    Zaitseva M; Peden K; Golding H
    Biochim Biophys Acta; 2003 Jul; 1614(1):51-61. PubMed ID: 12873765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-3 Lactone Mimetic Interacts with CD4 and HIV-1 Env Proteins, Hampering HIV-1 Infection without Inducing a Histopathological Alteration.
    Richichi B; Pastori C; Gherardi S; Venuti A; Cerreto A; Sanvito F; Toma L; Lopalco L; Nativi C
    ACS Infect Dis; 2016 Aug; 2(8):564-71. PubMed ID: 27626296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of peptides that recognize the CD4 binding domain of HIV-1 gp120.
    Fontenot JD; Tan X; Phillips DM
    AIDS; 1998 Aug; 12(12):1413-8. PubMed ID: 9727561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 entry and its inhibition.
    Pierson TC; Doms RW
    Curr Top Microbiol Immunol; 2003; 281():1-27. PubMed ID: 12932074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
    Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
    Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.